Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.

ADIL

Adial Pharmaceuticals (ADIL)

Adial Pharmaceuticals Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:ADIL
DateTimeSourceHeadlineSymbolCompany
22/04/202422:30GlobeNewswire Inc.Adial Pharmaceuticals Granted Key Patent from the United States Patent and Trademark OfficeNASDAQ:ADILAdial Pharmaceuticals Inc
10/04/202422:30GlobeNewswire Inc.Adial Pharmaceuticals Announces Peer-Reviewed Publication Highlighting Promising Safety Data and High Patient Compliance in a Clinical Trial of AD04 as a Potential Treatment for Alcohol Use DisorderNASDAQ:ADILAdial Pharmaceuticals Inc
02/04/202423:30GlobeNewswire Inc.Adial Pharmaceuticals Reports 2023 Fiscal Year Financial Results and Provides Business UpdateNASDAQ:ADILAdial Pharmaceuticals Inc
02/03/202411:00GlobeNewswire Inc.Adial Pharmaceuticals Announces Exercise of Warrants for $3.5 Million Gross ProceedsNASDAQ:ADILAdial Pharmaceuticals Inc
29/02/202401:30GlobeNewswire Inc.Adial Pharmaceuticals Awarded New Patent from the United States Patent and Trademark OfficeNASDAQ:ADILAdial Pharmaceuticals Inc
15/02/202407:22Edgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial ownership by individualsNASDAQ:ADILAdial Pharmaceuticals Inc
14/02/202401:15GlobeNewswire Inc.Adial Pharmaceuticals Awarded New Patent Notice of Allowance from the United States Patent and Trademark OfficeNASDAQ:ADILAdial Pharmaceuticals Inc
26/01/202408:30Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:ADILAdial Pharmaceuticals Inc
25/01/202416:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:ADILAdial Pharmaceuticals Inc
19/01/202408:15Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ADILAdial Pharmaceuticals Inc
19/01/202400:30GlobeNewswire Inc.Adial Announces Appointment of Tony Goodman as Chief Operating OfficerNASDAQ:ADILAdial Pharmaceuticals Inc
17/01/202408:17Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ADILAdial Pharmaceuticals Inc
13/01/202408:51Edgar (US Regulatory)Form S-3 - Registration statement under Securities Act of 1933NASDAQ:ADILAdial Pharmaceuticals Inc
21/12/202301:00GlobeNewswire Inc.Adial Pharmaceuticals Receives Final Reimbursement Payment from AdovateNASDAQ:ADILAdial Pharmaceuticals Inc
13/12/202308:36Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:ADILAdial Pharmaceuticals Inc
09/12/202303:08Edgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsNASDAQ:ADILAdial Pharmaceuticals Inc
30/11/202308:47Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ADILAdial Pharmaceuticals Inc
30/11/202308:05GlobeNewswire Inc.Adial Pharmaceuticals Regains Compliance with Nasdaq Listing RequirementNASDAQ:ADILAdial Pharmaceuticals Inc
29/11/202308:10Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ADILAdial Pharmaceuticals Inc
25/11/202301:24Edgar (US Regulatory)Form PRE 14A - Other preliminary proxy statementsNASDAQ:ADILAdial Pharmaceuticals Inc
20/11/202323:46Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:ADILAdial Pharmaceuticals Inc
20/11/202316:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:ADILAdial Pharmaceuticals Inc
15/11/202309:02GlobeNewswire Inc.Adial Pharmaceuticals Reports Third Quarter 2023 Financial Results and Provides Business UpdateNASDAQ:ADILAdial Pharmaceuticals Inc
09/11/202308:05Edgar (US Regulatory)Form S-1 - General form for registration of securities under the Securities Act of 1933NASDAQ:ADILAdial Pharmaceuticals Inc
06/11/202322:14Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ADILAdial Pharmaceuticals Inc
31/10/202323:30GlobeNewswire Inc.Adial Pharmaceuticals Chief Medical Officer and Key Opinion Leaders to Discuss “New Aspects in Substance Use Treatment” at The Annual International Society of Addiction Medicine ConferenceNASDAQ:ADILAdial Pharmaceuticals Inc
31/10/202308:24Edgar (US Regulatory)Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend]NASDAQ:ADILAdial Pharmaceuticals Inc
31/10/202308:18Edgar (US Regulatory)Form 8-K/A - Current report: [Amend]NASDAQ:ADILAdial Pharmaceuticals Inc
31/10/202308:17Edgar (US Regulatory)Form NT 10-Q/A - Notification of inability to timely file Form 10-Q or 10-QSB: [Amend]NASDAQ:ADILAdial Pharmaceuticals Inc
27/10/202308:20Edgar (US Regulatory)Form D - Notice of Exempt Offering of SecuritiesNASDAQ:ADILAdial Pharmaceuticals Inc
 Showing the most relevant articles for your search:NASDAQ:ADIL